Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Jun;229(6):866-72; discussion 872-3.
doi: 10.1097/00000658-199906000-00014.

The enigma of desmoid tumors

Affiliations

The enigma of desmoid tumors

J J Lewis et al. Ann Surg. 1999 Jun.

Abstract

Objective: To analyze patients with recurrent extremity desmoids, in whom the surgical therapeutic option was either major amputation or observation.

Summary background data: The biology and natural history of desmoid tumors are an enigma. These tumors invade surrounding structures and recur locally but do not metastasize. The morbidity of treating these tumors in the context of their relatively benign biology is uncertain.

Methods: Between July 1982 and June 1998, the authors treated and prospectively followed 206 patients with extremity desmoid tumors. All patients underwent standardized surgical resection, the surgical goal always being complete resection with negative margins. When tumors recurred, they were evaluated for reresection. Amputation was considered when resection was not possible because of neurovascular or major bone involvement, or in the presence of a functionless, painful extremity.

Results: During this period, 22 patients had disease that was not resectable without amputation. This was out of a total of 115 patients with primary disease and 91 patients with recurrent disease. All recurrences were local; in no patient did metastasis develop. In this group of 22 patients with unresectable disease, 7 underwent amputation and 15 did not. These 15 patients were followed, alive with disease, having no surgical resection. Four patients received systemic treatment with tamoxifen and nonsteroidal antiinflammatories, three received systemic cytotoxic chemotherapy, and two received both tamoxifen and chemotherapy. Six patients received no systemic treatment. The range of follow-up was 25 to 92 months. In all patients, there was no or insignificant tumor progression; in three patients who underwent observation alone, there was some regression of tumor. During follow-up, no patient has required subsequent amputation, and no patient has died from disease.

Conclusions: In desmoid tumors, aggressive attempts at achieving negative resection margins may result in unnecessary morbidity. Function- and structure-preserving procedures should be the primary goal. In select patients, whose only option is amputation, it may be prudent to observe them with their limb and tumor intact.

PubMed Disclaimer

Figures

None
Figure 1. Distribution algorithm of 206 patients treated and followed with desmoid tumors of the extremity. Of these, 22 tumors were resectable only with amputation, and 15 patients underwent no resection and no amputation.
None
Figure 2. Axial T1-weighted magnetic resonance imaging scan of shoulder in patient 3. The right image was taken 12 months after the left one. This patient underwent no treatment, and the tumor remained stable during this time.
None
Figure 3. Axial Fat Sat magnetic resonance imaging scan of thigh in patient 7. The right image was taken 23 months after the left one. The patient underwent no treatment, and the tumor remained stable during this time.
None
Figure 4. Sagittal T1-weighted magnetic resonance imaging scan of knee in patient 13. The right image was taken 15 months after the left one. The patient underwent no treatment and the tumor remained stable during this time.

References

    1. Alman BA, Pajerski ME, Diaz-Cano S, Corboy K, Wolfe HJ. Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder. Diagn Mol Pathol 1997; 6: 98–101. - PubMed
    1. Wara WM, Phillips TL, Hill DR, et al. Desmoid tumors—treatment and prognosis. Radiology 1977; 124: 225–226. - PubMed
    1. Li M, Cordon-Cardo C, Gerald WL, Rosai J. Desmoid fibromatosis is a clonal process. Hum Pathol 1996; 27: 939–943. - PubMed
    1. Merchant NP, Lewis JJ, Leung DH, Woodruff JM, Brennan MF. Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer (in press). - PubMed
    1. Wold LE, Weiland LH. Tumefactive fibro-inflammatory lesions of the head and neck. Am J Surg Pathol 1983; 7: 477–482. - PubMed

Publication types